We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of KIN yet.

KIN Hedge Fund Activity: Q4 2021 in Review

0 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2021, worth a combined $0 — down 100% from $11K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of KIN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was CVA Family Office, exiting entirely with an estimated $11K sold.

  • 0 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2021, down from 1 in Q3 2021.
  • Funds reported $0 of Kindred Biosciences, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Kindred Biosciences, Inc. positions in Q4 2021 and 1 closed out, a net change of -1 holder.
  • The largest Kindred Biosciences, Inc. seller in Q4 2021 was CVA Family Office, an estimated $11K sold.

Based on aggregated 13F filings for Q4 2021.